Skip to main content
20 articles related to "Shla G"

Articles

Original Research

Published on 22 May 2023

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients

in Cancer Immunity and Immunotherapy

  • Oliver Hoffmann
  • Sebastian Wormland
  • Ann-Kathrin Bittner
  • Julian Hölzenbein
  • Esther Schwich
  • Sabine Schramm
  • Hana Rohn
  • Peter A. Horn
  • Rainer Kimmig
  • Sabine Kasimir-Bauer
Frontiers in Immunology
doi 10.3389/fimmu.2023.1188030
  • 3,473 views
  • 4 citations

Brief Research Report

Published on 26 Jul 2021

Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients – Brief Research Report

in Non-Neuronal Cells

  • Adriel S. Moraes
  • Vinicius O. Boldrini
  • Alliny C. Dionete
  • Marilia D. Andrade
  • Ana Leda F. Longhini
  • Irene Santos
  • Amanda D. R. Lima
  • Veronica A. P. G. Silva
  • Rafael P. C. Dias Carneiro
  • Raphael P. S. Quintiliano
Frontiers in Cellular Neuroscience
doi 10.3389/fncel.2021.705618
  • 4,025 views
  • 6 citations

Original Research

Published on 05 Nov 2025

Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesicles

in Cancer Immunity and Immunotherapy

  • Kianny Kimberly Silva-Krebs
  • Evelyn Maciel de Oliveira
  • Carlos Arthur Athayde
  • Pedro Barbosa da Fonseca
  • Fernanda G. De Felice
  • Fabiana Rabe Carvalho
  • Marcelo Sá Araújo
  • Flávio Barbosa Luz
  • Andrea Alice Silva
  • Luciana Pantaleão
Frontiers in Immunology
doi 10.3389/fimmu.2025.1670611
  • 1,521 views
  • 1 citation